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Abstract
Background: An episode of peripheral immune response may create long-lasting alterations in the neural network.
Recent studies indicate a glial involvement in synaptic remodeling. Therefore it is postulated that both synaptic
and glial changes could occur under the peripheral inflammation.
Results: We tested this possibility by in vivo two-photon microscopy of dendritic spines after induction of a
peripheral immune response by lipopolysaccharide (LPS) treatment of mice.
We observed that the spines were less stable in LPS-treated mice. The accumulation of spine changes gradually
progressed and remained low over a week after LPS treatment but became significantly larger at four weeks. Over
eight weeks after LPS treatment, the fraction of eliminated spines amounted to 20% of the initial population and
this persistent destabilization resulted in a reduction of the total spine density.
We next evaluated glial activation by LPS administration. Activation of microglia was confirmed by a persistent
increase of Iba1 immunoreactivity. Morphological changes in microglia were observed two days after LPS
administration and were partially recovered within one week but sustained over a long time period.
Conclusions: These results indicate long-lasting aggravating effects of a single transient peripheral immune
response on both spines and microglia. The parallel persistent alterations of both spine turnover and the state of
microglia in vivo suggest the presence of a pathological mechanism that sustains the enhanced remodeling of
neural networks weeks after peripheral immune responses. This pathological mechanism may also underlie long-
lasting cognitive dysfunctions after septic encephalopathy in human patients.
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Background
Sepsis is a serious medical condition caused by a severe
immune response to infection. Recent studies have
demonstrated that patients recovered from septic
conditions can have long-term cognitive impairment,
including memory deficits and attention disorders [1].
How impairment of brain functions persists long after
recovery from sepsis still remains to be poorly under-
stood. Peripheral injection of bacterial lipopolysacchar-
ide (LPS), endotoxin from gram-negative bacteria,
mimics the pathological state of sepsis. LPS interacts
with Toll-like receptors on macrophages and initiates
production of a variety of proinflammatory cytokines
including tumor necrosis factor (TNF)- a,i n t e r l e u k i n
(IL)-1b, and IL-6 [2,3]. These cytokines cross the blood-
brain barrier, activate cells of the brain capillaries, and
also activate vagal afferents. Subsequently, these
responses further induce the synthesis of prostaglandins
[4-6] and cytokines within the brain that cause fever
and general feelings of illness [7].
Consistent with cognitive impairment in human
subjects who recovered from sepsis, peripheral adminis-
tration of LPS in rodents has been shown to affect cogni-
tive functions [8]. In line with these findings, LPS has
also been demonstrated to impair long-term potentiation
(LTP), a key cellular process in learning and memory
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any medium, provided the original work is properly cited.[9,10]. How does LPS-evoked peripheral inflammation
affect functions of the neural network? One obvious pos-
sibility is through alterations of glia [11]. Microglial cells
are resident immune cells in the CNS [12,13] and have
the ability to respond to inflammation by changing their
shape from ramified to amoeboid morphology [14] or by
changing the expression profile of marker molecules,
such as ionized calcium binding adaptor molecule 1
(Iba1) [15,16]. Recent in vivo imaging studies reported
rapid motility of microglial processes [17,18]. Direct con-
tact of microglia with synapses may also be involved in
synapse stripping in pathological conditions [19].
The neuronal network in the mammalian forebrain
has been shown to be intrinsically dynamic [20,21] and
in vivo time-lapse two-photon microscopy of dendritic
spines in the mouse neocortex has provided direct evi-
dence of network remodeling [22,23]. Although previous
in vivo imaging studies reported remodeling of synapses
after induction of ischemia [24,25] and in neurodegen-
erative conditions [26,27], long-lasting changes of
synapses triggered by peripheral inflammatory responses
have not yet been investigated. Here we performed in
vivo spine imaging after LPS treatment. Surprisingly,
mild and transient peripheral inflammation induced
long-lasting changes of spine dynamics, associated with
p e r s i s t e n tu p - r e g u l a t i o no fI b a 1e x p r e s s i o ni nm i c r o g l i a .
The parallel sustained alterations of both spine turnover
and the state of microglia in vivo m a yu n d e r l i el o n g -
term cognitive impairment after septic encephalopathy
in human patients.
Methods
Animals
All experimental procedures were carried out in compli-
ance with the institutional guidelines of the University
of Tokyo and the government. This study was approved
by the animal welfare ethics committee at the University
of Tokyo, Faculty of Medicine with the approval ID of
P08-016. Every effort was made to minimize the suffer-
ing and the number of animals used.
For in vivo imaging and histochemical analyses, both
male and female C57BL/6 transgenic mice aged two to
three months were used. For in vivo spine imaging,
transgenic mice expressing green fluorescence protein
(GFP) under the control of the Thy1 promoter (Thy1-
GFP M mice) were used [28]. To visualize microglia,
transgenic mice expressing GFP under the control of
the Iba1 promoter (Iba1-GFP mice) were used [29].
Drug treatment
E.coli lipopolysaccharide (LPS, strain O111:B4, Sigma-
Aldrich (catalog number L4391)) was dissolved in a sal-
ine solution at a concentration of 0.2 mg/mL and stored
at -30°C in small aliquots. Mice were intraperitoneally
injected with a single dose of LPS (0.5 mg/kg). The
optimal dose of LPS was determined from the morpho-
logical changes in microglia two days after LPS injection
with doses of 0.1, 0.3, 0.5 or 5.0 mg/kg. We observed
morphological changes in microglia at doses higher than
0.5 mg/kg. Injection of LPS at 5.0 mg/kg induced severe
behavioral responses, while sickness behavior was less
prominent at lower doses. From these pilot experiments,
we selected a dose of 0.5 mg/kg for experiments with
spine imaging and glial activation.
Surgery
Mice were deeply anesthetized intraperitoneally
with ketamine (100 mg/kg body weight) and xylazine
(10 mg/kg body weight) diluted in a saline solution.
After the disappearance of the pinching response the
hair of the scalp was shaved and a midline incision of
the scalp was made. Periosteum tissue was removed
with a surgical blade and the somatosensory area (-1.5
mm from Bregma and 2.0 mm from the midline) was
marked by stereotactic coordinates. A small rectangular
metal plate with a round hole was glued on the skull
and mice were fixed to the immobilized stage (SR-5M,
Narishige) with a heating pad to maintain body tem-
perature. The skull above the imaging area was thinned
through the round hole of the metal plate. The thinning
was initially done over a small area (a 1.5 × 1.5 mm
square) with a high speed micro-drill (KM11, Minimo).
When the bone reached ~50 μm in thickness, further
thinning was performed manually with micro surgical
blades (NORDLAND blade, Salvin Dental) until the
skull reached ~15 μm in thickness. We paid particular
attention not to push the skull during the thinning pro-
cess. The final imaging window was a 0.5 × 0.5 mm
square. For the repetitive imaging, the brain vasculature
pattern was recorded with a CCD camera (GZ-MG70,
Victor).
In vivo imaging
A scanning microscope (FV-300, Olympus) equipped
with a pulsed laser (MaiTai HP, Spectra Physics) was
used for imaging with a water immersion objective lens
(1.05 NA, 25x, Olympus). The wavelength was 920 nm
and the average power of the laser after the objective
lens was between 10 and 20 mW. The imaging area was
234 μm×2 3 4μm (low magnification) or 78 μm×7 8
μm (high magnification), with an imaging depth 50 μm
from the surface of the neocortex (Layer 1) and the step
size of the z stack set to 0.75 μm. The pixel sizes of
single horizontal images were set to 512 × 512. Low
magnification images, together with images of the vascu-
lature pattern taken with a CCD camera, served as the
reference maps for repetitive acquisition of higher mag-
nification images from the same cortical area. For
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was removed and the skin was sutured. The mice were
kept on the heating pad until they recovered from the
anesthesia and were returned to their home cage. To
minimize the damage to the brain tissue due to the re-
thinning of the skull, mice were imaged twice for most
of the experiments and three times at the maximum.
Fixation of animals and immunohistochemistry
Wild type or Iba1-GFP mice were sampled before or
two, seven, 28 days after LPS injection. Mice were dee-
ply anesthetized with pentobarbital and perfused trans-
cardially with PBS followed by 4% paraformaldehyde.
Brains were removed and further fixed in 4% parafor-
maldehyde overnight at 4°C. Slices were made with a
vibratome (DTK-1000, Dosaka EM) with a 50 μm thick-
ness. Slices from wild type mice were stained with anti-
Iba1 antibody (1/500, Wako Pure Chemicals) or anti-
glial fibrillary acidic protein (GFAP) antibody (1/3000,
Sigma-Aldrich) followed by the fluorescence conjugated
secondary antibodies to visualize the microglia or astro-
cytes. Mice from various time intervals after LPS injec-
t i o no rc o n t r o lw e r ef i x e do nt h es a m ed a ya n ds l i c e s
were stained at the same time. Images were obtained by
using a laser scanning confocal microscope (FV-1000,
Olympus) or a wide-field fluorescence microscope (BX-
50, Olympus) under the same illumination and collec-
tion conditions.
Data analysis
All analyses of spine dynamics, densities, and estima-
tions of sizes were done manually using National
Institutes of Health ImageJ software (http://rsb.info.
nih.gov/ij). We could identify both spines and filopodia
[30] but analyzed only dendritic protrusions classified
as spines in this study (Figure 1) [31]. The same den-
dritic segments (5-50 μm length) were identified from
the image stacks at different time points and spines
were selected and classified into three groups. New
spines were those identified only at the second time
point. Eliminated spines were those present only at the
first time point but missing at later points. Spines pre-
sent at both time points were categorized as stable
spines. The number of spines in each group was
counted and both the formation and elimination rates
were calculated as the percentages of eliminated spines
and newly formed spines to the total number of spines
examined respectively. To ensure the tissue move-
ments and rotations three-dimensional stacks were
always used for the analysis. We did not analyze struc-
tures that projected mainly along the imaging axis,
b e l o wo ra b o v ed e n d r i t e s .W ec o n s i d e r e das p i n ei n
t h es e c o n di m a g et ob et h es a m es p i n ea si nt h ef i r s t
image if the second image spine was located within 0.5
μm of the expected location based on its spatial rela-
tionship to adjacent spines or landmarks like axonal
and dendritic orientation.
For the morphological analysis of spines, we selected
dendritic segments where eliminated spines could be
identified. Binary images were constructed by appropri-
ate thresholding to determine the outline of spines. The
length from the neck to the tip of a spine (a) and the
maximum width of a head (b) were measured manually
and the sum of these two values was taken as a para-
meter reflecting spine size.
For the spine density analysis, we used the same den-
dritic segments as in the spine turnover analysis. We
selected the dendritic segments whose lengths were
more than 20 μm for the spine density calculation.
Spine density was calculated as (N of spines)/(lengths of
dendritic segments).
For the analysis of Iba1 expression we took 41 images
at the z step of 1 μm and a maximum projection image
was generated from the same number of stack images
for all the individual slices. Images were obtained with a
laser scanning confocal microscope (FV-1000, Olympus)
under the same illumination and collection conditions.
The total fluorescence intensity of projection image was
measured by ImageJ software. The background intensity
was subtracted from the total fluorescence intensity.
The intensity values were normalized to the mean inten-
sity value of the control.
The density of microglia was calculated from the same
slices as used for the measurement of intensity. The
number of Iba1-positive cell bodies was manually
counted three-dimensionally from 41 image stacks. The
number of microglia was normalized to the mean
number of microglia in the control.
Imaris v6.1.3 (Bitplane, Zurich, Switzerland) was used
for the three-dimensional analysis of microglial pro-
cesses. Surface rendering of GFP-positive microglia from
z-stacks of confocal microscope images was performed
and the lengths of processes were determined by mea-
s u r i n gt h ed i s t a n c ef r o mt h ec e n t r o i do fac e l lb o d yt o
the tip along the processes.
Structural dynamics of microglia were quantified from
time-lapse imaging of soma and protrusions in vivo.
Images were obtained every three min for 30 min. We
took 51 images at the z step of one μm for each time-
interval image. The analysis was performed on maxi-
mum-intensity projections of fluorescence image stacks.
The same number of stack images was used for each
cell analysis. The dynamics of microglia were evaluated
by measuring the length of extension and retraction of
microglial protrusions. Ten processes of microglia were
randomly selected and the length of extension and
retraction was measured to compare the overlay of two
images at two different time points.
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comparisons were made by an ANOVA test, followed
by a Tukey’s test (Figures 2, 3, 5, 6, 7). Statistical signifi-
cance was evaluated using Student’st - t e s t( F i g u r e4 ) .
Differences were considered to be significant if p < 0.05.
Cytokine array analysis
Tissue extracts from control and LPS-treated mice
were screened by using a cytokine antibody array kit
(Array1, RayBiotech Inc., Atlanta, GA, USA) according
to the manufacturer’s instructions. After euthanasia of
mice with a large dose of pentobarbital, the neocortex
and the hippocampus were dissected from the fore-
brain and homogenized in a lysis buffer. Brain extracts
were then centrifuged at 10,000 × g for 10 min at 4°C.
Protein concentrations of supernatants were deter-
mined and equal amounts of protein were incubated
with array membranes. The signals generated by
enhanced chemiluminescence were recorded by
ChemiDoc XRS (Bio-Rad, Tokyo, Japan). For the analy-
sis of chemiluminescence signals from cytokine spots,
total signals were calculated and then background
intensity was subtracted. The averaged optical densities
of the six positive controls on the membrane were
calculated and the optical densities of cytokine spots
were divided by these values. These normalized values
were compared and the ratio between control and
LPS-treated mice was calculated.
Figure 1 Two-photon microscopy of dendritic spines. (A1) Typical morphologies of dendrites in the superficial layer of the neocortex
detected by in vivo two-photon microscopy. This is a projection image of z-stacks. Scale bar, 10 μm. (A2) Higher magnification view of the
dendritic segment marked by the rectangle in A1. The image was generated from a montage of several adjacent optical sections separated by
0.75 μm in the Z-direction. Scale bar, 5 μm. (B) In vivo imaging of dendritic segments at two time points (day 0 and day 28). These images were
also generated from a montage of several adjacent optical sections separated by 0.75 μm in z-direction, illustrating stable spines (arrowheads)
and eliminated spines (arrows). Scale bar, 5 μm.
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Transient peripheral immune response induces long-
lasting changes of spine dynamics in vivo
Turnover of excitatory synapses in the neocortex with
or without stimulation of the peripheral immune system
can be quantitatively evaluated by two-photon imaging
of dendritic spines in vivo.W ev i s u a l i z e da p i c a ld e n -
drites of pyramidal neurons in the somatosensory cortex
of adult transgenic mice expressing GFP under the con-
trol of the Thy1 promoter in a small subset of the CNS
neurons (Thy1-GFP M mice) [28]. We selected the
thinned-skull method in this study, because of the less
prominent effects of this surgical procedure on the acti-
vation of glial cells [32]. To detect spines generated and
eliminated, we obtained image stacks of GFP-filled den-
drites by two-photon microscopy at two time points
separated by two days, seven days, four weeks or eight
weeks (Figure 1A). A pair of image stacks was compared
and spines present in both image stacks, and those pre-
sent only at a single time point were identified manually
(Figure 1B). After identification and classification of
spines, the fractions of newly formed spines and elimi-
nated spines were calculated. The fraction of spines
added or eliminated in unperturbed animals was low
and comparable to a previous report [33]. The fraction
of dynamic spines was less than 5% over a period of
seven days, 5% over four weeks, and still less than 10%
over a period of eight weeks (see Figure 3B).
We challenged Thy1-GFP M mice with peripheral
administration of LPS and measured the turnover rate
of spines. The dose of LPS (0.5 mg/kg) was set to the
minimal dose sufficient for up-regulation of Iba-1,
which is a well-characterized marker of microglial acti-
vation. The protocols for imaging were set to be identi-
cal for control and LPS-treated groups, except that the
LPS-treated group received a single intraperitoneal
injection of LPS after acquisition of spine images on the
first day. We first determined if there were any altera-
tions in spine densities after LPS administration (Figure
2). Spine densities (estimated from images taken over
intervals from two days to four weeks within the same
volume of the cortex) did not show prominent differ-
ences, with a tendency for a slight decline [33,34]. How-
ever, there was a significant reduction in spine density
at eight weeks after LPS treatment, indicating a late
impact of LPS treatment on the cortical network.
Delayed changes in the total spine density may be
derived from persistent changes in the spine addition/
elimination rates triggered by LPS. To test this possibi-
lity, we calculated the fractions of added or eliminated
spines (Figure 3A). Within the first week after LPS
treatment, these dynamic fractions were not significantly
larger than the corresponding fractions in the control
group (Figure 3B). However, when we waited for four
weeks, the fractions of added or eliminated spines accu-
mulated after LPS treatment were significantly larger
than the corresponding fractions in the control group
(5.5% (control) versus 11.0% (LPS-treated) for spine
elimination, 5.2% (control) versus 10.7% (LPS-treated)
for spine formation at four weeks). Spine elimination
was further enhanced by LPS treatment when we
waited for eight weeks (7.2% (control) versus 20.9%
Figure 2 Temporal change of spine density after LPS treatment. Average spine densities at different time points after LPS treatment were
calculated and normalized against the value at day zero (before LPS administration in the LPS-treated group). Spine densities were maintained
close to the original value until 28 days after LPS injection. However, there was a late decline of spine density in LPS-treated group and the
difference was statistically significant (*, p < 0.05).
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Page 5 of 16Figure 3 Persistent up-regulation of spine turnover in mice treated with LPS. (A) Spine turnover rates were measured as illustrated in the
scheme. (B) Spine turnover rates of control and LPS-treated mice measured at two, seven, 28, and 56 days. Upward bars (black) and downward bars
(red) represent the formation and elimination rate of spines, respectively. Spines formed and eliminated in control: 2.4 ± 1.4% and 2.5 ± 1.1% over two
days (N = 6) (B1), 2.6 ± 0.4% and 2.7 ± 0.6% over seven days (N = 6) (B2), 5.2 ± 2.1% and 5.5 ± 0.6% over 28 days (N = 6) (B3), 6.8 ± 1.1% and 7.2 ±
1.1% over 56 days (N = 3) (B4). Spines formed and eliminated after LPS injection: 1.7 ± 1.8% and 3.3 ± 1.1% over two days (N = 3) (B1), 2.2 ± 1.4% and
3.1 ± 0.5% over seven days (N = 3) (B2), 10.7 ± 1.5% and 11.0 ± 1.2% over 28 days (N = 6) (B3), 12.4 ± 4.9% and 20.9 ± 3.5% over 56 days (N = 4) (B4).
These data were statistically compared between control and LPS treatment (spines formed: p > 0.5 for two days; p > 0.5 for seven days; p < 0.001 for
28 days; p > 0.1 for 56 days; spines eliminated: p > 0.1 for two days; p > 0.1 for seven days; p < 0.001 for 28 days; p < 0.001 for 56 days). ***, p < 0.001.
(C) Spine turnover measured with a fixed interval but with different days of the first imaging.
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match that of elimination in the LPS-treated group
(6.8% (control) versus 12.4% (LPS-treated)). This unba-
lance of addition and elimination of spines could explain
the reduction of the total spine density at eight weeks
after LPS treatment.
The selective increase of the dynamic spine fraction at
late time points could be explained by either an accu-
mulation of small changes gradually over time or by
abrupt up-regulation of dynamics at specific time points.
To discriminate between these two possibilities, we
imaged dendritic spines with intervals fixed to one
week, but altered the first imaging days to be either
zero, seven, 14, or 21 days after LPS treatment. We
could not detect up-regulation of spine dynamics in any
of these time segments (Figure 3C), supporting the first
possibility that the accumulation of small changes only
becomes obvious four weeks after LPS treatment. In
other words, these results indicate the presence of per-
sistent alterations in spine dynamics lasting well beyond
several weeks after transient and mild activation of the
peripheral immune system.
Morphological characteristics of eliminated spines
Next, we evaluated morphological characteristics of
spines eliminated early (within one week) or late (later
than four weeks) after the initial time point of the spine
imaging. Previous reports on spine lifetime in slices
indicated that spines with larger volumes had longer
lifetimes [35]. Therefore, small spines may have a higher
probability for elimination after LPS treatment in vivo.
On the other hand, if spine elimination is a stochastic
process with no preference for size, we might not detect
any differences in spine size between groups with differ-
ent lifetimes. To discriminate between these possibilities,
we evaluated the morphology of individual spines by cal-
culating the sum of their lengths and widths (Figure
4A). This measurement suggests that indeed there exists
differences in morphology between spines eliminated
within one week and those that remained (Figure 4B1).
Eliminated spines tended to be smaller than the stable
ones (p < 0.001). However, a similar comparison
between spines eliminated within one month and those
that survived for one month did not show such a ten-
dency (Figure 4B2). Thus, we consider the spines with a
life-time of less than a week morphologically distinct
from the remaining spine population.
LPS treatment increased the fraction of added and
eliminated spines only in a late phase. At four weeks
after LPS treatment, the fraction of eliminated spines
was 10%, twice as large as the fraction in the control
(5%). If LPS treatment affected a subset of spines, such
as those with smaller volumes, we might be able to
detect changes in the frequency distribution of spines
eliminated late after LPS treatment. However, the mor-
phology of spines eliminated within one week or one
month was not significantly different between the LPS-
treated group and the control group (Figure 4B and 4C),
suggesting that there was no preferential impact of LPS
treatment on a subset of spines with a specific
morphology.
We conclude that spines destined to be eliminated
within a week are smaller than the average in both con-
trol and LPS-treated conditions. LPS increased the frac-
tion of spines to be eliminated late after LPS treatment,
but the morphological difference of this LPS-sensitive
fraction could not be detected by comparison of spine
images, indicating that the late effect of LPS is to
increase the probability of spine elimination irrespective
of the spine size.
LPS-induced alterations in glial properties
The in vivo imaging of LPS-treated Thy1-GFP Mm i c e
indicated the presence of persistent alterations in spine
dynamics lasting well beyond several weeks after transient
activation of the peripheral immune system. Peripheral
immune responses can secondarily induce changes in glial
components in the CNS, especially in astrocytes and
microglial cells [36,37]. We performed immunohistochem-
istry of the neocortex two, seven and 28 days after LPS
treatment to detect activation of astrocytes and microglial
cells. We could not detect up-regulation of the astrocytic
marker GFAP. However, Iba1, a marker of microglial
activation, was up-regulated at all time points examined
(p < 0.001 for two, seven, 28 days) (Figure 5A and 5B).
Notably, up-regulated Iba1 immunoreactivity was main-
tained even at 28 days after LPS injection. There was also
a specific increase of microglial density at 28 days after
LPS treatment (p < 0.01) (Figure 5C). These results indi-
cate prolonged activation and late proliferation of micro-
glia following a single peripheral administration of LPS.
Peripheral injection of LPS may induce morphological
changes of microglia. To test this possibility, we mea-
sured the length of microglial processes using a trans-
genic mouse line expressing GFP in microglia under the
control of the Iba1 enhancer element (Iba1-GFP mice)
[29]. Cytoplasmic GFP signals from microglia in Iba1-
GFP mice reflect cellular morphology more precisely
than the immunoreactivity of endogenous Iba1, which
may reflect both cell shape and intracellular distribution
of the protein. There was a transient shrinkage of
microglial processes assessed by GFP signal two days
after LPS treatment (p < 0.001), but the processes
showed re-extension at seven and 28 days after LPS
treatment (Figure 6). Consistent with the up-regulation
of the endogenous Iba1 gene, GFP expression under the
control of the Iba1 promoter also increased progres-
sively after LPS treatment.
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Page 7 of 16Figure 4 Relationship between spine size and spine elimination. (A) The sizes (both length (a) and width (b)) of spines were measured as
illustrated. The sum of the values “a” and “b” was calculated and utilized as an index of spine size. (B1) Spines eliminated within two or seven
days were smaller than the spines maintained for the same period. Images are comparisons over two days. An arrow indicates an eliminated
spine. The bar graph shows the combined data from images taken over two or seven days, as the frequency distribution of each population was
indistinguishable. (B2) When spines were imaged with intervals of 28 days, the sizes of eliminated spines were similar to those of stable spines.
An arrow indicates an eliminated spine. (C1) Spines eliminated within two or seven days were smaller than the stable spines also in the LPS-
treated group. An arrow indicates an eliminated spine. (C2) Spines eliminated 28 days after LPS treatment had comparable sizes with those
maintained. An arrow indicates an eliminated spine. Importantly, the average sizes of eliminated spines between control and LPS-treated groups
were not different at two different time points (less than seven days in B1/C1, at 28 days in B2/C2), indicating that the effect of LPS is not
selective for a specific size of spines. ***, p < 0.001. Scale bars, 2 μm.
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treatment but recovered from the initial shrinkage of
their processes at time points later than seven days. A
previous study reported the importance of process moti-
lity and contact with synapses for the regulation of
synapse remodeling by microglia [19]. To evaluate the
extent of microglial process motility, we visualized the
dynamics of microglial processes using in vivo two-
photon microscopy of Iba1-GFP mice. Time-lapse
images were obtained every three min for 30 min. The
temporal profiles of process extension and retraction
were created from images of microglia without stimula-
tion (Figure 7A1), microglia two days after LPS treat-
ment (Figure 7A2), and 28 days after LPS treatment
(Figure 7A3). The average velocities of process remodel-
ing determined from time-lapse images (Figure 7B) were
Figure 5 LPS induced persistent activation of microglia. (A) Immunohistochemical analyses were performed with fixed cortical slices from
control and LPS treated mice at different time points. Slices were stained either with anti-Iba1 antibody for microglia or anti-GFAP antibody for
astrocytes. Projection images are shown. Scale bar in the upper column, 10 μm; bar in the lower column, 400 μm. (B) Temporal profile of
enhanced Iba1 expression after LPS treatment. To evaluate expression of Iba1, the total intensity of fluorescence was measured and the averages
were plotted as values normalized to the control (N: number of mice, n: number of slices). The intensity of fluorescence was significantly
increased after two days of LPS treatment and this increasing trend was maintained until 28 days. (C) Late increase in the number of microglia
after LPS treatment. The number of microglia was counted and the averages were plotted as values normalized to the control (N: number of
mice, n: number of slices). The number of microglia was significantly increased only at 28 days after LPS treatment. **, p < 0.01, ***, p < 0.001.
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Page 9 of 16Figure 6 Morphological changes of microglia after LPS treatment. (A) High magnification images of microglia in Iba1-GFP mice. Mice were
either unperturbed or received LPS injection and were sacrificed for immunohistochemical analyses two, seven, and 28 days later. Scale bar, 10
μm. (B) Total lengths of microglial processes were measured and the averages are shown as lengths normalized to the control (N: number of
mice, n: number of microglia). The shrinkage of processes was observed at two days but they recovered their original lengths seven days after
LPS injection. GFP signals from the microglial processes were enhanced even at later time points (seven and 28 days), but this may be due to
either real increase in process diameters or increases in the GFP protein content. ***, p < 0.001.
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Page 10 of 16Figure 7 Unaltered dynamics of microglial processes in LPS-treated mice. (A) Morphology of microglia imaged by in vivo two-photon
microscopy of Iba1-GFP mice. A1 shows a cell from a mouse without LPS administration. A2 and A3 show cells from LPS-treated mice at two and 28
days after LPS treatment, respectively. Scale bar, 10 μm. (B1) An example of a microglial cell utilized for time-lapse analysis (identical cell shown in A3).
This image shows the morphology at zero time point, with an overlay of green lines (numbered from 1 to 10) on individual processes. The tips of
these green lines were recorded and their distances between adjacent time frames (3 min intervals) were calculated as an index of process motility
shown in C and D. (B2) Binary images of a microglial process (green line) extracted from time-lapse sequences in the image area marked by a dotted
rectangle in B1, illustrating the extent (yellow line) of rapid growth and shrinkage (red line). Numbers in the upper left corner indicate elapsed timei n
min. Scale bar, 2 μm. (C) The motility of microglial processes. Extension and retraction of processes were plotted for three representative processes
with time intervals of three min. Positive values indicate process extension and negative values indicate retraction. (D) Summation of absolute
distances of extension and retraction during 30 minutes was calculated and the average speeds per frame (three min) were estimated from 10
processes of control and LPS-treated mice. The average motility was comparable among control and LPS-treated groups.
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and groups with different intervals between LPS treat-
ment and in vivo imaging (Figure 7C and 7D). These
observations indicate microglia in both acute and
chronic phases after LPS treatment are able to interact
with synapses with their highly dynamic processes.
Brain cytokine and chemokine profiles after LPS
treatment
We next asked whether soluble factors, such as TNF-a
and IL-6, in the neocortex were persistently modulated
after LPS treatment. Inflammation induces the expres-
sion of a variety of cytokines and chemokines in micro-
glia [38]. Profiles of 22 different cytokines and
chemokines in lysates taken from the neocortex of mice
were evaluated by using antibody array membranes. We
prepared brain lysate from mice sacrificed at multiple
time points (one hr, two days, or 28 days) after LPS
treatment (N = 1 for one hr and two days (data not
shown), N = 3 for 28 days) and from control mice (N =
3). Signals were detected by a chemiluminescence
method and were compared with the signal intensity of
control mice (Figure 8A and 8B). We did not detect
more than a two-fold increase or decrease in the level of
cytokines/chemokines tested at any time point (Figure
8C). To test the sensitivity of our membrane array sys-
tem, we challenged the mice with a ten-fold higher dose
of LPS (5 mg/kg) (N = 1) that reportedly induces the
amoeboid transformation of microglia and up-regulation
of cytokines. In this condition, we successfully detected
the up regulation of some cytokines (IL-6, IL-12, and
TNF-a; data not shown) as reported previously [37].
This demonstrated that the detection system was indeed
capable of measuring marked changes in cytokines/che-
mokines. Thus, at the LPS dose used in our imaging
experiments, spine turnover rate might be modulated by
other soluble factors secreted from microglia. However,
we can not exclude the possibility that activated micro-
glia, which corresponds to a small fraction of the cells
present in the neocortex, secreted factors whose amount
is under the limit of sensitivity of our detection system.
Discussion
In this study, we addressed the question of how periph-
eral immune responses can modulate network remodel-
ing of the neocortex in vivo.W ei m a g e dd e n d r i t i c
spines in vivo and analyzed spine dynamics over a per-
iod of several days to weeks after transient activation of
the peripheral immune system with LPS. Within a week
after LPS treatment, spine dynamics were low and com-
parable to those in control mice, indicating a minimal
acute effect of systemic LPS treatment. Surprisingly, the
fraction of newly formed or eliminated spines accumu-
lated during four weeks after LPS treatment was twice
as large as the proportion in control mice. The
enhanced spine turnover was associated with persistent
activation of microglial cells. The persistent modification
of both spine dynamics and microglial activity suggests
long-lasting effects of a single transient peripheral
immune response on brain functions.
Peripheral immune response triggers sustained up-
regulation of spine turnover in vivo
In vivo imaging of dendritic spines can be achieved by
two different surgical techniques. The first approach,
using chronic open-skull glass windows, provides clear
imaging windows for efficient two-photon excitation in
the deeper cortical layers without a limit on imaging time
points [31]. The second approach, using thinned skull
windows, gives less efficient excitation of the deep corti-
cal layers and is limited in the number of repetitive ima-
ging, due to the technical difficulty of thinning the same
cranial tissue multiple times [22]. Previous reports indi-
cate that the open-skull window is associated with transi-
ent glial activation, which is not present after proper
thinned-skull surgery [32]. Because our research goal was
to assess the influence of mild peripheral immune
response on the remodeling of the neural network, we
had to exclude any possibility of inducing inflammation
in the brain parenchyma due to the imaging protocol
itself. Therefore, we imaged dendritic spines through a
thinned-skull window in this study and successfully con-
firmed the remarkably stable nature of dendritic spines
(turnover of < 10% over one month) [22].
In order to activate the peripheral immune system, we
administered a single low dose of LPS intraperitoneally.
This treatment induced persistent enhancement of spine
turnover in vivo. We used the lowest possible dose of
LPS (0.5 mg/kg) to induce up-regulation of Iba-1 immu-
noreactivity in microglia and there was no sign of acute
neuronal degeneration in the brain (data not shown). A
p r e v i o u ss t u d yb yS p a r k m a net al.u s i n gas i n g l ei n t r a -
peritoneal injection of LPS at the low dose of 0.25 mg/
kg reported the presence of classic signs of sickness
behavior, including decreased locomotion, hunched pos-
ture, piloerection, and anorexia [39]. Therefore we can-
not eliminate the possibility that emotional and
cognitive alterations acutely induced by sickness-related
behavioral changes are partly responsible for alterations
in spine dynamics. On later days of in vivo imaging,
however, mice are fully recovered and it is less likely
that the initial sickness behavior is the direct cause of
the enduring enhancement of spine dynamics. Instead,
we propose that persistent activation of microglia over a
period of more than several weeks plays an important
role in enhanced synapse remodeling.
Synapse formation and elimination are believed to be
the basis for the plastic changes of neuronal circuits
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Page 12 of 16Figure 8 Brain cytokine expression after LPS treatment. (A) Images of cytokine array membranes incubated with brain homogenates from
control mice (N = 3) and mice treated with LPS 28 days before preparation of brain homogenates (N = 3). (B) The arrangement of tested
cytokines on the membrane. (C) The density of each spot was measured and the ratios between control and LPS-treated groups were
calculated. There was no substantial increase or decrease in expression of the cytokines we tested.
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should be associated with functional changes in the
neural network. Then, what are the functional outcomes
of spine dynamics after LPS treatment? Interestingly,
Sparkman et al. reported that LPS administration
affected the performance of mice in the Morris water
maze more profoundly on later test days [39]. The dif-
ference in distance swam became significant only after
three days had elapsed following LPS injection. This
time course may reflect accumulation of network remo-
deling in the hippocampus over the period of several
days, which may be paralleled by the enhanced spine
turnover we observed in the neocortex. A possible link
between cognitive impairment observed in LPS-treated
rodents and alterations in the neural network is rein-
forced by a previous study showing LPS-dependent
modification of synaptic plasticity, such as LTP [9]. For
example, Shaw et al. reported impairment of both the
dentate gyrus LTP in vivo and performance of a water
maze task in rats that received a single dose of LPS
(0.25 mg/kg) intraperitoneally [42]. Cytokines up-regu-
lated by LPS administration, such as TNFa and IL-1b,
are also known to function as modulators of synaptic
plasticity [43-45]. It is possible that elevation of cyto-
kines initiated by peripheral LPS treatment modulates
LTP/long-term depression (LTD)-like mechanisms in
vivo and subsequently triggers structural remodeling of
the neural network, including addition and elimination
of spines.
Persistent microglial activation triggered by peripheral
immune responses may be involved in enhanced spine
dynamics
Neuronal networks in the mammalian forebrain are
intrinsically dynamic [20,46] and are regulated by inter-
actions with glia [19,47-49]. Microglial cells constitute
the major cell type which responds to peripheral inflam-
mation in the CNS [37]. Therefore we suspected that
microglial cells directly modulated spine dynamics in
response to intraperitoneal administration of LPS. As we
already discussed, in vivo imaging through an open-skull
glass window results in relatively high turnover rate of
spines, together with transient activation of microglia. In
contrast, with the thinned-skull window technique,
much less spine dynamics and microglia activation were
observed [32]. In pathological states, microglial pro-
cesses show enhanced motility [17,18] and preferentially
associate with synapses and may facilitate their decon-
struction [19]. How microglia regulate neural networks
in vivo is still poorly understood. Microglia may induce
synapse remodeling via direct mechanical contact of
their processes with synapses, or they may release solu-
ble factors which destabilize nearby synapses. In order
to evaluate these possibilities, we performed
morphological and biochemical analyses of microglia in
the neocortex after LPS administration.
In order to address the structural interactions between
microglia and spines, we first analyzed the morphologi-
cal transition of microglia with enhanced Iba1 expres-
sion after LPS administration. Iba1 is a small EF hand
calcium binding protein involved in Rac and calcium
signaling pathways [15]. Therefore, morphological
changes of microglia could be related to the reorganiza-
tion of the actin network through the Rac pathway. We
observed both enhanced Iba1 expression and shrinkage
of microglial processes two days after LPS treatment.
This observation confirms that a single peripheral injec-
tion of LPS is sufficient to trigger activation of micro-
glia. Iba1 expression was up-regulated between seven
and 28 days after LPS administration and the number of
microglia was also increased during the same period.
These observations are consistent with the idea that
microglia activation is not only maintained, but gradu-
ally enhanced over a time period of several weeks after
LPS treatment. Our in vivo imaging of Iba1-GFP mice
revealed that microglial processes had comparable moti-
lity before and after LPS treatment. Because the density
of microglia increased late after LPS treatment, the fre-
quency of individual synapses to receive contact of acti-
vated microglia may also be enhanced. This effect
possibly underlies the progressive elimination of spines
after LPS treatment. In the current studies, we restricted
our analysis of microglial changes up to one month and
we did not investigate the direct association between
dendritic spines and microglial processes. However, the
dynamic nature of microglial processes and their inter-
action with synapses were reported recently (17-19).
Our present observation of the alterations in spine
remodeling suggests an association with the change in
microglia. Further studies are necessary to elucidate
whether microglial contact is involved in the spine
elimination.
Cytokines that are secreted from glial cells in the
brain can affect both synaptic functions and spine mor-
phology [43,44,50]. In animal models of neurodegenera-
tive disorders and aging, there are reports of
proliferating activated microglia and the increased levels
of proinflammatory and anti-inflammatory cytokines
together with impairments of spine density and mor-
phology [51]. Systemic administration of LPS also
increases several types of cytokines in the peripheral
blood, mainly TNF-a,I L - 1 b, and IL-6 [7]. In order to
detect soluble factors up-regulated in the brain during
the persistent enhancement of spine turnover, we mea-
sured the levels of cytokines and chemokines in brain
extracts prepared 28 days after LPS treatment. However,
we were unable to detect increased expression of multi-
ple cytokines. These results suggest that either signals
Kondo et al. Molecular Brain 2011, 4:27
http://www.molecularbrain.com/content/4/1/27
Page 14 of 16mediated by soluble factors may not be involved in
synapse destabilization or, alternatively, factors we have
not yet tested play a critical role. It is also possible that
cytokines or chemokines we tested are indeed involved
in synapse remodeling, but the concentration sufficient
for exerting their effect is below the limit of detection.
In this study, we found that mild and transient periph-
eral inflammation induced long-lasting changes of spine
dynamics over a period of several weeks and persistent
up-regulation of Iba1 expression in microglia. Although
we could not demonstrate convincing evidence for the
interrelationship between these two alterations, recent
findings showing the interaction between microglia and
synapses (17-19) indicate that activation of microglia
may be associated with spine remodeling. However, the
relationship between microglia and spine changes in our
present study remains to be fully elucidated in future
experiments. The parallel sustained alterations of both
spine turnover and the state of microglia in vivo may
underlie long-term cognitive impairment after peripheral
inflammation, which may be relevant to the neurological
problems of patients who have recovered from septic
conditions.
Conclusions
In this study, we used in vivo two-photon imaging in
mice to test whether peripheral immune responses
affected cortical synapses. We observed parallel
increases in spine dynamics and microglial activities
after LPS treatment. Although a more definitive causal
relationship between spine and microglial changes
should be clarified in the future, our results implicate
that microglial activities may affect spine dynamics.
These observations could help our understanding of the
long-term cognitive impairment of septic human
patients.
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